Entrada Therapeutics Inc. (TRDA)

11.30

-0.64 (-5.36%)

At close: Mar 03, 2025, 3:59 PM

11.33

0.27%

After-hours: Mar 03, 2025, 04:00 PM EST

Entrada Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Net Income	65.63M	-6.68M	-94.62M	-51.16M	-26.52M	-5.1M
Depreciation & Amortization	-6.25M	2.84M	1.9M	1.12M	326K	104K
Stock-Based Compensation	17.91M	13.11M	9.89M	2.53M	325K	294K
Other Working Capital	-119.84M	139.12M	-16.4M	-2.71M	-349K	-193K
Other Non-Cash Items	n/a	-5.78M	151K	74K	20K	-6.27M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-118.85M	136.31M	-11.11M	-3.42M	282K	174K
Operating Cash Flow	-41.56M	139.8M	-93.79M	-50.86M	-25.57M	-10.8M
Capital Expenditures	-3.16M	-5.61M	-2.89M	-4.58M	-2.33M	-630K
Acquisitions	n/a	n/a	145.76M	n/a	7K	n/a
Purchase of Investments	-437.72M	-407.21M	-221.98M	n/a	n/a	n/a
Sales Maturities Of Investments	413.08M	274.43M	76.21M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-145.76M	n/a	n/a	n/a
Investing Cash Flow	-27.8M	-138.4M	-148.65M	-4.58M	-2.32M	-630K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	284K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.36M	1.63M	479K	116.77M	50.09M	38K
Financial Cash Flow	102.96M	21.04M	479K	307.46M	50.09M	38K
Net Cash Flow	33.61M	22.45M	-241.96M	252.02M	22.2M	-11.39M
Free Cash Flow	-44.72M	134.19M	-96.67M	-55.44M	-27.89M	-11.43M